60 results
8-K
EX-3.2
THRX
Theseus Pharmaceuticals Inc
14 Feb 24
Completion of Acquisition or Disposition of Assets
10:44am
provided by law, the Certificate of Incorporation or these Bylaws. In the case of a special meeting, the purpose or purposes for which the meeting … contact information on such list. Such list shall be open to the examination of any stockholder for any purpose germane to the meeting at least 10 days
8-K
EX-3.1
THRX
Theseus Pharmaceuticals Inc
14 Feb 24
Completion of Acquisition or Disposition of Assets
10:44am
of the Corporation in the State of Delaware at such address is The Corporation Trust Company.
ARTICLE III.
The purpose of this Corporation is to engage in any
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
14 Feb 24
Third party tender offer statement (amended)
10:35am
of Parent or Purchaser for the purpose of maintaining and preserving the CVR Products and seeking, negotiating and executing Disposition Agreements … (the “CVR Register”) for the purpose of (i) identifying the Holders of CVRs and (ii) registering CVRs and Permitted CVR Transfers thereof. The CVR
SC TO-T/A
Concentra Merger Sub II, Inc.
30 Jan 24
Third party tender offer statement (amended)
8:23am
.
The purpose of this Amendment is to amend and restate the Schedule TO and the Offer to Purchase, including to disclose that on January 29, 2024, Parent … amount to be provided under the terms of the Merger Agreement). The purpose of this Amendment is to amend and restate the Schedule TO and the Offer
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
30 Jan 24
Third party tender offer statement (amended)
8:23am
SHEET
INTRODUCTION
SPECIAL FACTORS
BACKGROUND OF THE OFFER; CONTACTS WITH THESEUS.
PURPOSE OF THE OFFER AND PLANS FOR THESEUS.
REPORTS, OPINIONS … or Purchaser for the purpose of maintaining and preserving the CVR Products and seeking, negotiating and executing Disposition Agreements, (iii) the maintenance
SC 14D9
z54tijyo1c0z562
10 Jan 24
Tender offer solicitation
9:47am
SC TO-T
EX-99
zcszs pe7y
10 Jan 24
Third party tender offer statement
8:51am
SC TO-T
EX-99
ere4xy8name93tsibx
10 Jan 24
Third party tender offer statement
8:51am
SC TO-T
EX-99
lcfu2aoge33rdaepc
10 Jan 24
Third party tender offer statement
8:51am
SC TO-T
xgqbk1 c9qp
10 Jan 24
Third party tender offer statement
8:51am
8-K
EX-2.1
v97oovl3al0e 0xup
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
8-K
wt1rsc4
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
8-K
EX-10.2
597 4wzx7vip5r3t
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.1
u6caj
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.3
7t56v4inrzjjw4 426v
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.4
93f6pu5 81
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.1
7c478awyaiiowqzwwqnk
13 Nov 23
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
4:06pm
8-K
EX-10.2
i5d9fwm6 f1
13 Nov 23
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
4:06pm